0001519449-25-000040
SEC filingSkyward Specialty's notes reveal nine underwriting divisions with gross written premiums of $1.12B H1 2025, robust equity growth, and no debt changes.
As of June 30, 2025, Skyward Specialty reported total assets of $4.34B, up from $3.73B at year-end 2024. Cash and cash equivalents stood at $136.6M, with restricted cash of $36.5M. Total investments reached $2.08B, including $1.63B in AFS fixed maturities, $35.3M HTM securities, and $214.3M short-term investments. Shareholders' equity grew 13.3% to $899.9M, driven by net income of $80.9M and positive OCI of $19.5M. Net debt (notes payable $100M plus subordinated debt $19.6M) remained flat at $119.6M, representing a manageable leverage ratio.
The notes disclose minimal purchase commitments. However, the company has $25.7M in unfunded commitments to equity method investments, including $21.5M to RedBird Capital Partners. Additionally, $225.7M in trust accounts held for reinsurance recoverables are not on-balance-sheet. No material long-term supply or capacity commitments were reported.
Skyward Specialty did not repurchase shares or pay dividends during the period. Debt levels remained unchanged, with the FHLB loan of $57M and revolving credit facility of $43M. Capital allocation focused on organic growth, as evidenced by a 10.2% increase in net earned premiums year-over-year in H1 2025. The company also invested $2.0M in intangible assets/goodwill.
While the company operates as a single reportable segment, Note 6 provides granular gross written premiums by nine underwriting divisions for H1 2025: Accident & Health ($123.7M), Agriculture & Credit ($159.4M), Captives ($145.4M), Construction & Energy ($149.2M), Global Property ($130.7M), Professional Lines ($79.3M), Specialty Programs ($148.6M), Surety ($78.5M), and Transactional E&S ($105.5M). The diversified mix highlights strong contributions from Agriculture (up 99% YoY) and Specialty Programs (up 33% YoY). Geographic mix is not disclosed, but all operations are predominantly U.S.-based. Net underwriting income improved 22.9% to $59.7M in H1 2025, reflecting disciplined underwriting.
Operating cash flow (CFO) of $184.9M for H1 2025 was robust, exceeding net income of $80.9M by a factor of 2.3x, indicating strong cash conversion and non-cash adjustments (adjustments of $104.0M). Year-over-year, CFO improved 60.5% from $115.2M, driven by higher net income and favorable working capital changes.
Capex was minimal at $1.3M (0.7% of CFO), suggesting low capital intensity typical of insurance firms. The bulk of investing outflows ($169.3M net) came from purchases of fixed maturity and equity securities, reflecting the company's investment portfolio management strategy rather than asset expansion.
Financing activities showed no net cash usage in 2025 (vs. $9.5M used in 2024), with no share repurchases or dividends paid. The company ended the period with $173.2M in cash and equivalents, up from $157.5M at the start of the period. Overall, cash flow quality is high, supported by strong CFO and minimal capex requirements, though significant investment purchases may reduce liquidity if not matched by operating inflows.